about
Fucoidan and cancer: a multifunctional molecule with anti-tumor potentialLRRK2 inhibitors and their potential in the treatment of Parkinson's disease: current perspectivesDetection of nucleophosmin and FMS-like tyrosine kinase-3 gene mutations in acute myeloid leukemiaFucoidan enhances the therapeutic potential of arsenic trioxide and all-trans retinoic acid in acute promyelocytic leukemia, in vitro and in vivo.Fucoidan Suppresses the Growth of Human Acute Promyelocytic Leukemia Cells In Vitro and In Vivo.Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's diseaseNigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin miceLRRK2-mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients
P50
Q27021858-B4675C8D-A211-45EE-97C8-ABAEFAACF8A4Q28078899-4FC93C49-8AF5-4174-968B-EF0A3AFF2D72Q35006113-EE57AD8C-9EE5-4AA0-8264-F2D7D28FB6BDQ37564637-FD6D5484-5E46-4B0B-B58D-C4396639498CQ38846422-2895C9B4-779D-4A83-B2C4-082E418B3AB5Q58603525-E9B75EAB-8041-4E6B-BF6B-4A81F60F1246Q59797902-FCCD90EE-AB27-4D98-8EAC-B3CB514431E4Q64786372-ADB1DD1E-5B93-40C4-AE97-A72A57E89087
P50
description
researcher
@en
name
Farzaneh Atashrazm
@en
type
label
Farzaneh Atashrazm
@en
prefLabel
Farzaneh Atashrazm
@en
P31
P496
0000-0003-3471-8160